A Mechanistic Study Of Mifamurtide (MTPPE) In Patients With Metastatic And/Or Recurrent Osteosarcoma
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2019
Price : $35 *
At a glance
- Drugs Mifamurtide (Primary)
- Indications Osteosarcoma
- Focus Therapeutic Use
- Acronyms MEMOS
- 07 Aug 2019 Status changed from completed to discontinued.
- 21 Mar 2017 Status changed from active, no longer recruiting to completed.
- 25 Jan 2017 This trial has been completed in Italy, according to European Clinical Trials Database.